Cargando…

A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury

BACKGROUND: It has recently been demonstrated that palmitoylethanolamide (PEA), an endogenous lipid amide belonging to the N-acylethanolamine family, exerts neuroprotection in central nervous system (CNS) pathologies. In recent studies, we have demonstrated that treatment with PEA significantly redu...

Descripción completa

Detalles Bibliográficos
Autores principales: Paterniti, Irene, Impellizzeri, Daniela, Di Paola, Rosanna, Navarra, Michele, Cuzzocrea, Salvatore, Esposito, Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728012/
https://www.ncbi.nlm.nih.gov/pubmed/23880066
http://dx.doi.org/10.1186/1742-2094-10-91
_version_ 1782278791727415296
author Paterniti, Irene
Impellizzeri, Daniela
Di Paola, Rosanna
Navarra, Michele
Cuzzocrea, Salvatore
Esposito, Emanuela
author_facet Paterniti, Irene
Impellizzeri, Daniela
Di Paola, Rosanna
Navarra, Michele
Cuzzocrea, Salvatore
Esposito, Emanuela
author_sort Paterniti, Irene
collection PubMed
description BACKGROUND: It has recently been demonstrated that palmitoylethanolamide (PEA), an endogenous lipid amide belonging to the N-acylethanolamine family, exerts neuroprotection in central nervous system (CNS) pathologies. In recent studies, we have demonstrated that treatment with PEA significantly reduced inflammatory secondary events associated with spinal cord injury (SCI). Since oxidative stress is considered to play an important role in neuroinflammatory disorders, in the present work we studied a new composite, a formulation including PEA and the antioxidant compound luteolin (Lut), subjected to an ultramicronization process, co-ultraPEALut. We investigated the effect of co-ultraPEALut (in the respective fixed doses of 10:1 in mass) in both an ex vivo organotypic spinal cord culture model and an in vivo model of SCI. METHODS: For the organotypic cultures, spinal cords were prepared from mice at postnatal day 6 and were cut into transverse slices of 400 μm thickness to generate the lumbar organotypic slice cultures. After 7 days of culturing, the slices were mechanically injured onto the center of the slice and the co-ultraPEALut was applied at different concentrations (0.00009, 0.0009 and 0.009 g/l) 1 hour before damage. For in vivo studies, SCI was induced in mice through spinal cord compression by the application of vascular clips (force of 24 g) to the dura via a four-level T5 to T8 laminectomy, and co-ultraPEALut (1 mg/kg ip) was administered at 1 and 6 hours after SCI. At 24 hours after SCI, mice were sacrificed and the spinal cords were collected for further evaluation. Additional animals were treated similarly and sacrificed 10 days after SCI. RESULTS: Pretreatment with co-ultraPEALut significantly reduced cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression in a concentration-dependent manner, restored neuronal nitric oxide synthase (nNOS) expression at all three tested concentrations, and protected cells by cell death (MTT assay) in spinal cord organotypic cultures. Moreover, we demonstrated in vivo that co-ultraPEALut 1 mg/kg reduced the severity of trauma induced by compression and improved the motor activity evaluated at 10 days post-injury. CONCLUSION: The present study demonstrates that the protective effect of PEA on SCI-associated neuroinflammation could be improved by co-ultramicronization with Lut possibly due to its antioxidant properties.
format Online
Article
Text
id pubmed-3728012
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37280122013-07-31 A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury Paterniti, Irene Impellizzeri, Daniela Di Paola, Rosanna Navarra, Michele Cuzzocrea, Salvatore Esposito, Emanuela J Neuroinflammation Research BACKGROUND: It has recently been demonstrated that palmitoylethanolamide (PEA), an endogenous lipid amide belonging to the N-acylethanolamine family, exerts neuroprotection in central nervous system (CNS) pathologies. In recent studies, we have demonstrated that treatment with PEA significantly reduced inflammatory secondary events associated with spinal cord injury (SCI). Since oxidative stress is considered to play an important role in neuroinflammatory disorders, in the present work we studied a new composite, a formulation including PEA and the antioxidant compound luteolin (Lut), subjected to an ultramicronization process, co-ultraPEALut. We investigated the effect of co-ultraPEALut (in the respective fixed doses of 10:1 in mass) in both an ex vivo organotypic spinal cord culture model and an in vivo model of SCI. METHODS: For the organotypic cultures, spinal cords were prepared from mice at postnatal day 6 and were cut into transverse slices of 400 μm thickness to generate the lumbar organotypic slice cultures. After 7 days of culturing, the slices were mechanically injured onto the center of the slice and the co-ultraPEALut was applied at different concentrations (0.00009, 0.0009 and 0.009 g/l) 1 hour before damage. For in vivo studies, SCI was induced in mice through spinal cord compression by the application of vascular clips (force of 24 g) to the dura via a four-level T5 to T8 laminectomy, and co-ultraPEALut (1 mg/kg ip) was administered at 1 and 6 hours after SCI. At 24 hours after SCI, mice were sacrificed and the spinal cords were collected for further evaluation. Additional animals were treated similarly and sacrificed 10 days after SCI. RESULTS: Pretreatment with co-ultraPEALut significantly reduced cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression in a concentration-dependent manner, restored neuronal nitric oxide synthase (nNOS) expression at all three tested concentrations, and protected cells by cell death (MTT assay) in spinal cord organotypic cultures. Moreover, we demonstrated in vivo that co-ultraPEALut 1 mg/kg reduced the severity of trauma induced by compression and improved the motor activity evaluated at 10 days post-injury. CONCLUSION: The present study demonstrates that the protective effect of PEA on SCI-associated neuroinflammation could be improved by co-ultramicronization with Lut possibly due to its antioxidant properties. BioMed Central 2013-07-23 /pmc/articles/PMC3728012/ /pubmed/23880066 http://dx.doi.org/10.1186/1742-2094-10-91 Text en Copyright © 2013 Paterniti et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Paterniti, Irene
Impellizzeri, Daniela
Di Paola, Rosanna
Navarra, Michele
Cuzzocrea, Salvatore
Esposito, Emanuela
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
title A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
title_full A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
title_fullStr A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
title_full_unstemmed A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
title_short A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
title_sort new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728012/
https://www.ncbi.nlm.nih.gov/pubmed/23880066
http://dx.doi.org/10.1186/1742-2094-10-91
work_keys_str_mv AT paternitiirene anewcoultramicronizedcompositeincludingpalmitoylethanolamideandluteolintopreventneuroinflammationinspinalcordinjury
AT impellizzeridaniela anewcoultramicronizedcompositeincludingpalmitoylethanolamideandluteolintopreventneuroinflammationinspinalcordinjury
AT dipaolarosanna anewcoultramicronizedcompositeincludingpalmitoylethanolamideandluteolintopreventneuroinflammationinspinalcordinjury
AT navarramichele anewcoultramicronizedcompositeincludingpalmitoylethanolamideandluteolintopreventneuroinflammationinspinalcordinjury
AT cuzzocreasalvatore anewcoultramicronizedcompositeincludingpalmitoylethanolamideandluteolintopreventneuroinflammationinspinalcordinjury
AT espositoemanuela anewcoultramicronizedcompositeincludingpalmitoylethanolamideandluteolintopreventneuroinflammationinspinalcordinjury
AT paternitiirene newcoultramicronizedcompositeincludingpalmitoylethanolamideandluteolintopreventneuroinflammationinspinalcordinjury
AT impellizzeridaniela newcoultramicronizedcompositeincludingpalmitoylethanolamideandluteolintopreventneuroinflammationinspinalcordinjury
AT dipaolarosanna newcoultramicronizedcompositeincludingpalmitoylethanolamideandluteolintopreventneuroinflammationinspinalcordinjury
AT navarramichele newcoultramicronizedcompositeincludingpalmitoylethanolamideandluteolintopreventneuroinflammationinspinalcordinjury
AT cuzzocreasalvatore newcoultramicronizedcompositeincludingpalmitoylethanolamideandluteolintopreventneuroinflammationinspinalcordinjury
AT espositoemanuela newcoultramicronizedcompositeincludingpalmitoylethanolamideandluteolintopreventneuroinflammationinspinalcordinjury